Tag: FDA
Cigar News: District Court Judge Deems Warning Labels for Premium Cigars Illegal
Today, United States District Court Judge, Amit Mehta, deemed that the the warning label requirements for premium cigars imposed by the FDA are illegal. Mehta threw out the warning requirements for premium cigars with the reasoning because the FDA did not properly analyze the different usage patterns between premium cigars.
Read More
Cigar News: FDA Testing Deadline Delayed
The FDA has delayed a deadline that was originally Nov. 8, 2019 for reporting the testing results for potentially harmful constituents in every cigar and pipe tobacco product sold in the United States.
Read More
Cigar News: IPCPR Announces Cigaraction.org
IPCPR has launched a new grassroots website, cigaraction.org. This site is a resource for retailers and consumers to get involved with public policy issues that affect premium cigars. This launch coincides with their first grassroots campaign urging Congress to support a premium cigar exemption provision in the annual spending bill. Over time, this site will serve as the center of IPCPR’s grassroots effort with the cigar community for multiple federal and state initiatives.
Read More
5 Days Left to Submit Comments to the FDA
Last month, the FDA extended the deadline for public comments on how/if it should regulate premium cigars. That deadline is July 25th, giving you 5 more days to submit comments.
Read More Cigar News: Federal Judge Delays Cigar Warning Requirements
Earlier today, D.C. District Court Judge Amit Mehta issued an injunction prohibiting the U.S. Food & Drug Administration from enforcing its warning label requirements on cigars and pipe tobacco. The warning label requirements for packaging and advertising were slated to go into effect on August 10th. Judge Mehta’s order delays any enforcement of the requirement until at least 60 days after the conclusion of an appeal currently underway. No date has been set for a court to hear the appeal.
Read More Cigar News: FDA Will Re-Evaluate Premium Cigar Regulation
The FDA is taking another look at premium cigars in a move that anti-tobacco groups fear could weaken regulations. It’s the latest push under Commissioner Scott Gottlieb to undertake a sweeping overall of tobacco and nicotine regulation. The FDA recently took the first step in lowering the amount of nicotine in cigarettes. It also said it’s seeking information on the role flavors, including menthol, play in attracting people to tobacco products and alternatives like e-cigarettes.
Read More
Cigar News: House Bill Passes with Premium Cigar Exemption
Earlier today the US House of Representatives passed a 12 bill spending package that includes a provision prohibiting the FDA from enforcing regulations against premium cigars. The bill, known as an omnibus appropriations package, passed the House by 211-198 votes and will now move to the Senate for consideration. Congress has until December 8th to pass spending legislation and fund the federal government.
Read More Cigar News: FDA, IPCPR & CRA Announce New Plan for Premium Tobacco
FOR IMMEDIATE RELEASE – July 28, 2017 – WASHINGTON, D.C. – Today, Commissioner of the U.S. Food & Drug Administration, Dr. Scott Gottlieb, announced a new comprehensive plan for the approach the agency will take to the regulation of tobacco products, placing an emphasis on a science-based method, that notes a “continuum of risk” that recognizes the differences in tobacco products.
Read More Cigar News: Senate Confirms Dr. Scott Gottlieb as FDA Commissioner
Earlier today the United States Senate confirmed Dr. Scott Gottlieb as the next Commissioner of the Food & Drug Administration (FDA). IPCPR applauds the Senate’s decision to put thoughtful and experienced leadership at the head of an organization as critical as the FDA. Dr. Gottlieb’s confirmation puts a reform minded physician with experience in both the public and private sectors in charge of a regulatory body that has too often failed in its mission to protect the public health without needlessly hampering commerce in this country. The small business retailers and professional tobacconists that make up IPCPR are counting on the leadership of Dr. Gottlieb and the actions of his FDA to address and correct the onerous and catastrophic elements of last year’s Deeming Rule.
Read More
Cigar News: Famous Smoke Launches Cigar Smokers’ Rights Guide
EASTON, PA–(Marketwired – March 30, 2017) – Famous Smoke Shop, the leading online distributor of discounted premium cigars, has debuted their new interactive Cigar Smokers’ Rights Hub. Crafted in response to the US Food & Drug Administration’s 2016 Final Deeming Rule regarding premium cigars and other tobacco products, the Famous Smoke guide presents cigar enthusiasts with a history of legal actions affecting the tobacco industry. The Smokers’ Rights Hub also offers cigar smokers a detailed understanding of how FDA’s new regulations will negatively impact the premium cigar industry, and the legal challenges that have been mounted against the agency’s sweeping new rules.
Read More Cigar News: Allied Associations’ Federal Lawsuit Delayed One Month
The lawsuit filed jointly by IPCPR, CRA and CAA against the FDA will now be heard on August 30th, pushing the trial back from July 28th. The change was in response to the FDA’s original motion for a 60 day delay, in part to accommodate the transition from the Obama to Trump Administrations. The three trade associations agreed to the 30 day extension, however all three have made it clear to the federal government that any further delays would require extensions of pending compliance deadlines under the deeming rule.
Read More Cigar News: Dr. Scott Gottlieb Nominated as next FDA Commissioner
Today President Trump announced Dr. Scott Gottlieb as his pick to lead the Food & Drug Administration (FDA). Dr. Gottlieb has an impressive and extensive resume, with a wide-ranging background in both the private and public sectors and a M.D. from Mount Sinai School of Medicine. IPCPR welcomes the pick of Dr. Gottlieb and, If confirmed, we look forward to working with him as we continue to advocate for common-sense reforms to the recent FDA regulation needlessly harming the family owned small businesses retailers that make up IPCPR.
Read More
Recent Articles
